Biomedical Advanced Research and Development Authority (BARDA) Project for Radiation Exposure Research Awarded to SRI International
Published in PR newswire
(23.02.2010)
Get full text
Newspaper Article
Cempra Awarded $58 Million Contract to Develop Antibiotic for Pediatric Use and Biodefense by Biomedical Advanced Research and Development Authority (BARDA)
Published in PR newswire
(28.05.2013)
Get full text
Newspaper Article
Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthrax: Funding will be provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services
Published in PR Newswire
(03.08.2010)
Get full text
Newsletter
Elusys Receives Contract for up to $143 Million from the U.S. Federal Government to Fund Advanced Development of Anthim(R), a New Treatment for Anthrax: Funding awarded by BARDA (Biomedical Advanced Research & Development Authority); Anthim being developed to treat inhaled anthrax, one of the top bioterrorism threats
Published in PR Newswire
(04.01.2010)
Get full text
Newsletter
Cytori Gets Contract From Biomedical Advanced Research And Development Authority
Published in RTTNews
(28.09.2012)
Get full text
Newspaper Article
Cellerant Therapeutics Awarded $153 Million Contract by Biomedical Advanced Research and Development Authority
Published in Business Wire
(01.09.2010)
Get full text
Newspaper Article
HHS Establishes Office to Manage Biomedical Advanced Research and Development Authority
Published in U.S. Newswire
(26.04.2007)
Get full text
Newspaper Article
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics; Award is first of its kind public-private partnership with Biomedical Advanced Research and Development Authority; Funding will support development of drugs to fight
Published in M2 Presswire
(22.05.2013)
Get full text
Newspaper Article
Elusys Receives Contract for up to $143 Million from the U.S. Federal Government to Fund Advanced Development of Anthim(R), a New Treatment for Anthrax; Funding awarded by BARDA (Biomedical Advanced Research Development Authority); Anthim being developed to treat inhaled anthrax, one of the top bioterrorism threats
Published in PR newswire
(04.01.2010)
Get full text
Newspaper Article